Verastem | VSTM - Ordinary Share Capital


Verastem reported $87.84M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Alaunos Therapeutics USD 2.38M 172K Mar/2026
AstraZeneca USD 1.55B 44K Jun/2026
Curis USD 2M 10.93M Mar/2026
Cytokinetics USD 124.43M 2.17M Mar/2026
Gilead Sciences USD 1.24B 1000K Jun/2026
Incyte USD 200.98M 1.03M Jun/2026
Laboratory Of America USD 80.9M 1.4M Jun/2026
Novartis USD 1.9B 7.38M Jun/2026
Pfizer USD 5.7B 0 Jun/2026
Roche Holding CHF 796.77M 1.15M Jun/2026
TG Therapeutics USD 153.08M 2.23M Jun/2026
Verastem USD 87.84M 10.1M Mar/2026